C
Cyteir Therapeutics
Developing the next generation of synthetic lethal therapies to treat cancer
About Cyteir Therapeutics
Cyteir Therapeutics is a pioneering biotechnology company focused on developing novel therapeutics for cancer treatment through the biology of DNA repair and synthetic lethality. The company operates in the oncology market, primarily serving patients with various types of cancer. Cyteir's business model revolves around the discovery and development of drugs that induce selective self-destruction of cancer cells by targeting disease-induced RAD51 activity, leading to DNA damage overload. Revenue is generated through the development and commercialization of these specialized cancer therapies, as well as potential partnerships and licensing agreements with larger pharmaceutical companies.
Source: Dealroom company dataNews
Open roles
Cyteir Therapeutics in the Lexington ecosystem
The Cyteir Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
US Department of Health and Human Services
National Cancer Institute (NCI)
Series A7 investors entered at this stage
Bristol-Myers Squibb
Venrock
Novo Seeds
Novo Holdings
Droia Oncology Ventures
Lightstone Ventures
Celgene
Series B and later8 investors entered at this stage
RA Capital ManagementJanus Henderson Investors
Ally Bridge Group
CaaS Capital Management
Osage University Partners- AFAmple Plus Fund
- APAcuta Capital Partners
Avidity Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cyteir Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cyteir Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

